| Description | 1. Casticin (Vitexicarpin) can significantly reduce vascular inflammation, through inhibition of ROS-NF-κB pathway in vascular endothelial cells. 2. Casticin may become a potential leading drug in the therapy of prostate carcinoma. |
| Synonyms | Quercetagetin 3,6,7,4'-Tetramethyl Ether, Vitexicarpin, 蔓荆子黄素 |
| molecular weight | 374.34 |
| Molecular formula | C19H18O8 |
| CAS | 479-91-4 |
| Storage | keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 50 mg/mL (133.57 mM) Ethanol: 1 mg/mL |
| References | 1. Meng F M , Yang J B , Yang C H , et al. Vitexicarpin induces apoptosis in human prostate carcinoma PC-3 cells through G2/M phase arrest.[J]. Asian Pacific Journal of Cancer Prevention Apjcp, 2012, 13(12):6369. |